Ambu, DK0060946788

Ambu stock has its annual report on November 5, 2026

Published on 10/17/2026 at 19:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Third-quarter sales rose 8.80 percent to DKK 1.64 billion. Ambu stock last stood at EUR 10.40 on October 16, 2026, up 0.51 percent on Copenhagen.

Upcoming company reporting

  • Ambu's financial calendar lists November 5, 2026 for the annual report.
  • Third-quarter sales rose 8.80 percent to DKK 1.64 billion.
  • Ambu stock costs EUR 10.40 at Lang & Schwarz on October 16, 2026, 0.51 percent up on Copenhagen.
  • Ambu's valuation was a P/E of 41.02 with market capitalization of DKK 18.2 billion.
Ambu A/S (DK0060946788) zeigt fotorealistisch moderne Medizintechnik-Fertigung von Einweg-Endoskopen in steriler Reinraumumgebung, Illustration mit AI erstellt.

Ambu's financial calendar sets November 5, 2026 as the date for its annual report, according to Nasdaq. The date gives investors the next formal checkpoint after Ambu's fiscal year ended September 30, 2026. Ambu stock was last at EUR 10.40 at Lang & Schwarz on October 16, 2026 at 10:59 p.m. CEST, while the Copenhagen listing was up 0.51 percent on the session.

Third-quarter growth reached 8.80 percent

Ambu's latest reported quarter delivered sales of DKK 1.64 billion, compared with DKK 1.51 billion a year earlier. Net income reached DKK 156.00 million, according to Simply Wall St in its September 23, 2026 review. The comparison puts the quarter's sales increase at 8.61 percent year over year, using the reported DKK 1.51 billion prior-year figure.

Stock sits within its yearly range

On the Copenhagen listing, Ambu was last at DKK 78.35 on October 16, 2026 at 4:59 p.m. CEST. The 52-week range was DKK 56.25 to DKK 109.00, placing the last price 39.29 percent above the low and 28.12 percent below the high. Trading volume was 746,628 shares against an average of 792,464, a 5.79 percent shortfall.

Valuation and November 5 report

Ambu's market capitalization was DKK 18.2 billion on October 16, 2026, with a price-to-earnings ratio of 41.02 and a dividend yield of 0.01 percent. The annual report is scheduled for November 5, 2026, followed by Ambu's annual general meeting on December 2, 2026, according to the Nasdaq calendar.

Comparison with peers

Ambu: plus 0.51 percent, P/E 41.02, market capitalization DKK 18.2 billion
Getinge (Nasdaq Stockholm, SEK): plus 0.93 percent, P/E 26.61, market capitalization SEK 71.3 billion
Stryker (NYSE, USD): plus 0.49 percent, P/E 30.53, market capitalization USD 113.0 billion

What the next date brings

The November 5 report is the next scheduled company event, while the December 2 annual general meeting follows less than a month later. The calendar gives the stock two dated checkpoints for reviewing revenue growth, profitability and capital allocation.

Ambu's euro quote was EUR 10.40 at Lang & Schwarz on October 16, 2026 at 10:59 p.m. CEST. On Copenhagen, the share was up 0.51 percent on the session. The further course of trading is shown by the continuously updated real-time quote of Ambu stock.

Ambu stock facts

  • Company: Ambu A/S
  • ISIN: DK0060946788
  • Ticker: AMBU-B.CO
  • Primary exchange: Nasdaq Copenhagen
  • Price Lang & Schwarz (as of October 16, 2026, 10:59 p.m. CEST): EUR 10.40
  • Change on Copenhagen: plus 0.51 percent
  • Market capitalization: DKK 18.2 billion (as of October 16, 2026)
  • 52-week range: DKK 56.25-DKK 109.00 (as of October 16, 2026)
  • Sector / Industry: Health care / medical devices
  • Next earnings date: November 5, 2026

Market context: Current market reports.

More news and analyses on Ambu stock

Disclaimer...
en | DK0060946788 | AMBU | boerse | 70349021 | bgmi